Nasdaq Aveo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib...

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.52 and traded as high as $4.66. AVEO Pharmaceuticals shares last traded at $4.50, with a volume of 251,433 shares trading hands. A number […]

Brokerages expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) to report $25.60 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for AVEO Pharmaceuticals’ earnings. The lowest sales estimate is $24.95 million and the highest is $26.04 million. AVEO Pharmaceuticals reported sales of $7.56 million in the […]

Equities analysts expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) to post earnings per share of ($0.28) for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for AVEO Pharmaceuticals’ earnings. The highest EPS estimate is ($0.24) and the lowest is ($0.32). AVEO Pharmaceuticals reported earnings per share of ($0.48) in […]

AVEO Pharmaceuticals (NASDAQ:AVEO – Get Rating) issued its earnings results on Thursday. The biopharmaceutical company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.05), MarketWatch Earnings reports. AVEO Pharmaceuticals had a negative return on equity of 93.21% and a negative net margin of 126.12%. During the same […]